Bruker Corporation revised revenue guidance for the year 2022. The updated outlook for fiscal year 2022 includes organic revenue growth of 7% to 9% year-over-year, an increase of 1% from prior guidance. This is expected to lead to reported revenue growth in a range of 5% to 7%, consistent with prior guidance.